Get the Stockscreener App
1.39
2.11%
-0.03
After Hours:
1.39
Standard Biotools Inc stock is traded at $1.39, with a volume of 1.26M.
It is down -2.11% in the last 24 hours and up +16.81% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$1.42
Open:
$1.45
24h Volume:
1.26M
Relative Volume:
0.70
Market Cap:
$527.95M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.4632
EPS:
-0.95
Net Cash Flow:
$-46.12M
1W Performance:
+2.21%
1M Performance:
+16.81%
6M Performance:
-12.03%
1Y Performance:
-37.95%
1-Day Range:
$1.37
$1.45
1-Week Range:
$1.36
$1.5492
52-Week Range:
$0.92
$2.35
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.39 | 512.96M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
128.01 | 219.83B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.47 | 156.58B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
400.57 | 153.13B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.44 | 117.84B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.47 | 46.04B | 5.69B | 4.15B | 623.10M | 6.95 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Reversal Traders Monitor Standard BioTools Inc. for EntryReal-Time Trade Insights Spark Market Reactions - metal.it
Standard BioTools Inc. Approaches Psychological Resistance LevelBeginner Friendly Stock Selection Guide Updated - metal.it
How does Standard BioTools Inc. generate profit in a changing economyUnlock exclusive stock analysis for investors - jammulinksnews.com
What are the technical indicators suggesting about Standard BioTools Inc.Exceptional gains - jammulinksnews.com
What catalysts could drive Standard BioTools Inc. stock higher in 2025Discover stocks with superior performance - jammulinksnews.com
What are analysts’ price targets for Standard BioTools Inc. in the next 12 monthsFree Stock Data Feed Backed By Experts - jammulinksnews.com
Why is Standard BioTools Inc. stock attracting strong analyst attentionAchieve rapid capital gains with smart investing - jammulinksnews.com
How volatile is Standard BioTools Inc. stock compared to the marketCapitalize on strong market momentum - jammulinksnews.com
How many analysts rate Standard BioTools Inc. as a “Buy”Explosive trading opportunities - jammulinksnews.com
What drives Standard BioTools Inc. stock priceAccelerated wealth building - PrintWeekIndia
What institutions are buying Standard BioTools Inc. stock nowPhenomenal returns - jammulinksnews.com
What risks could impact Standard BioTools Inc. stock performanceSuperior risk-adjusted returns - jammulinksnews.com
What analysts say about Standard BioTools Inc. stockExceptional risk-adjusted gains - PrintWeekIndia
Is Standard BioTools Inc. a good long term investmentFree Stock Market Real-Time Monitoring - Autocar Professional
Standard BioTools Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional
Published on: 2025-07-22 13:31:08 - jammulinksnews.com
32,647 Shares in Standard BioTools Inc. (NASDAQ:LAB) Bought by Teacher Retirement System of Texas - Defense World
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewswire
Standard BioTools to report Q2 2025 financial results on August 11. - AInvest
Standard BioTools Sets Key Q2 Earnings Date: Here's When and How to Listen - Stock Titan
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):